How does active tuberculosis and its standard anti‑TB regimen affect menstrual cycles, and what management should be provided for menstrual irregularities and contraception in women undergoing treatment?

Menstrual Pattern on TB

Women with active pulmonary tuberculosis commonly experience reversible menstrual irregularities (affecting up to 66% of patients), most notably secondary amenorrhea and hypomenorrhea, which typically resolve in approximately 76% of cases after completing standard anti-TB treatment.

Effects of Active TB on Menstrual Cycles

Active tuberculosis significantly disrupts menstrual patterns through multiple mechanisms:

Common Menstrual Abnormalities

The most comprehensive evidence shows that menstrual abnormalities occur in approximately 66% of women with pulmonary TB 1. The specific patterns include:

• Secondary amenorrhea (26.5% of cases) - the most common abnormality
• Hypomenorrhea (20% of cases) - reduced menstrual flow
• Functional ovarian cysts (19.8% detected on transvaginal ultrasound)

These changes are predominantly reversible: approximately 76% of women with menstrual abnormalities resume normal cycles after completing anti-TB treatment 1.

Hormonal Disturbances

Women with TB demonstrate measurable hormonal changes 2:

• Significantly elevated testosterone levels compared to healthy controls
• Significantly reduced prolactin levels
• Lower (though not statistically significant) FSH and LH levels

These hormonal alterations likely contribute to the menstrual irregularities observed.

Impact of Anti-TB Treatment

Standard Regimen Effects

The standard 6-month anti-TB regimen consists of rifampicin, isoniazid, pyrazinamide, and ethambutol for 2 months, followed by rifampicin and isoniazid for 4 months 3. This treatment itself does not appear to cause additional menstrual dysfunction; rather, it facilitates restoration of normal cycles as the TB infection resolves 1.

Drug Interactions with Hormonal Contraception

Rifampicin significantly reduces the efficacy of hormonal contraceptives through hepatic enzyme induction. This is a critical consideration for women of reproductive age:

• Rifampicin decreases effectiveness of combined oral contraceptives, progestin-only pills, implants, and patches
• Copper IUD or depot medroxyprogesterone acetate (DMPA) are preferred contraceptive methods during rifampicin-containing TB treatment, as they are not affected by enzyme induction
• Levonorgestrel implants may have reduced efficacy with rifampicin 4

Management Approach

Initial Assessment and Counseling

All women of reproductive age starting TB treatment should receive pretreatment counseling that includes 1:

1. Explanation that menstrual irregularities are common and typically reversible
2. Discussion of contraceptive options compatible with rifampicin
3. Information about potential fertility implications

During Treatment

• Monitor menstrual patterns throughout the 6-month treatment course
• Provide appropriate contraception (copper IUD or DMPA preferred)
• Reassure patients that menstrual changes are expected and usually temporary

Post-Treatment Evaluation

If menstrual abnormalities persist beyond treatment completion or infertility develops, investigate for:

• Genital tuberculosis (affects fallopian tubes in 90%, endometrium in 70%, ovaries in 25% of FGTB cases) 5, 6, 7
• Tubal adhesions or damage
• Asherman's syndrome (intrauterine adhesions)

The risk of genital TB causing infertility is relatively low (0.7% in one study) but increases substantially in women with genital TB specifically 1, 2.

Special Considerations for Genital TB

Women with genital tuberculosis have more severe reproductive complications 2, 8:

• Higher rates of menstrual abnormalities (40% in genital TB vs. lower rates in pulmonary TB alone)
• Greater risk of infertility
• More pregnancy-related complications
• Common presentations: menstrual irregularities, abdominopelvic pain, infertility, or pelvic mass

Treatment for genital TB follows the same 6-month regimen as pulmonary TB (2 months RHZE, then 4 months RH), though some experts recommend 18-24 months for drug-resistant cases 6, 7.

Contraception Management Algorithm

For women on rifampicin-containing TB treatment:

1. First-line options (no interaction):

   • Copper IUD
   • DMPA (depot medroxyprogesterone acetate) injections

2. Avoid or use with caution:

   • Combined oral contraceptives (significantly reduced efficacy)
   • Progestin-only pills (reduced efficacy)
   • Levonorgestrel implants (may have reduced efficacy)
   • Contraceptive patches (reduced efficacy)

3. Backup contraception: Use barrier methods for 7 days when initiating hormonal methods during TB treatment 9

Key Clinical Pitfalls

• Do not dismiss menstrual irregularities as unrelated to TB - they are a common manifestation requiring patient education
• Do not prescribe standard hormonal contraceptives without counseling about rifampicin interactions
• Do not assume fertility is preserved - persistent abnormalities after treatment warrant investigation for genital TB
• Do not delay contraceptive counseling - unintended pregnancy during TB treatment poses management challenges, though treatment can continue safely in pregnancy 10, 11, 10